BUZZ-ConvaTec: Slumps as 'severely' bruised by supply issues

(Adds share performance, broker comment)

** Shares (Berlin: DI6.BE - news) in ConvaTec slump 17 pct to 7-mth lows in volume

** Shares set for all gains post-IPO to be wiped off and are trading at about 225p (co's IPO price)

** British medical technology co cuts FY organic revenue growth target to 1-2 pct vs. prior outlook of >4 pct

** Says "severely" hit by supply disruptions in wound care and ostomy divisions

** "We continue to see significant downside for the shares and reduce our target price to 220p to reflect the lower growth trajectory," Numis says, cutting the stock to "sell" from "reduce"

** Morgan Stanley (Xetra: 885836 - news) says Monday's update somewhat undermines the equity story set out at the time of the IPO last year, which was a combination of margin expansion from streamlining and organic growth re-acceleration from re-investing in the biz

** Over half of 30-day daily avg vol through in less than 1 hour of trading

** Monday's slump wipes off $1 bln from market value